Novel variant Hendra virus genotype 2 infection in a horse in the greater Newcastle region, New South Wales, Australia.
Journal
One health (Amsterdam, Netherlands)
ISSN: 2352-7714
Titre abrégé: One Health
Pays: Netherlands
ID NLM: 101660501
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
13
04
2022
revised:
23
07
2022
accepted:
24
07
2022
entrez:
24
10
2022
pubmed:
25
10
2022
medline:
25
10
2022
Statut:
epublish
Résumé
In October 2021, the first contemporary detection of Hendra virus genotype 2 (HeV-g2) was made by veterinary priority disease investigation in a horse near Newcastle, New South Wales, Australia, as part of routine veterinary priority disease surveillance. This discovery followed an update of Hendra virus diagnostic assays following retrospective identification of this variant from 2015 via sentinel emerging infectious disease research, enabling timely detection of this case. The sole infected horse was euthanized in moribund condition. As the southernmost recognised HeV spill-over detection to date, it extends the southern limit of known cases by approximately 95 km. The event occurred near a large urban centre, characterised by equine populations of diverse type, husbandry, and purpose, with low HeV vaccination rates. Urgent multi-agency outbreak response involved risk assessment and monitoring of 11 exposed people and biosecurity management of at-risk animals. No human or additional animal cases were recognised. This One Health investigation highlights need for research on risk perception and strategic engagement to support owners confronted with the death of companion animals and potential human exposure to a high consequence virus. The location and timing of this spill-over event diverging from that established for prototype HeV (HeV-g1), highlight benefit in proactive One Health surveillance and research activities that improve understanding of dynamic transmission and spill-over risks of both HeV genotypic lineages and related but divergent emerging pathogens.
Identifiants
pubmed: 36277112
doi: 10.1016/j.onehlt.2022.100423
pii: S2352-7714(22)00055-6
pmc: PMC9582560
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100423Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
Authors do not have a commercial or other association that might pose a conflict of interest. De-identified data on vaccination rates were supplied by Zoetis Inc.
Références
N Engl J Med. 2019 May 9;380(19):1804-1814
pubmed: 31067370
Proc Biol Sci. 2008 Apr 7;275(1636):861-9
pubmed: 18198149
PLoS One. 2014 Jun 17;9(6):e99965
pubmed: 24936789
J Infect Dis. 2019 May 24;219(12):1867-1878
pubmed: 30364984
PLoS One. 2017 Aug 2;12(8):e0182171
pubmed: 28767708
Emerg Infect Dis. 2014 Mar;20(3):372-9
pubmed: 24572697
Proc Natl Acad Sci U S A. 2022 May 31;119(22):e2122769119
pubmed: 35617431
Emerg Infect Dis. 2010 Feb;16(2):219-23
pubmed: 20113550
Emerg Infect Dis. 1995 Jan-Mar;1(1):31-3
pubmed: 8903153
PLoS One. 2015 Oct 15;10(10):e0140670
pubmed: 26469523
BMC Vet Res. 2017 Apr 13;13(1):103
pubmed: 28407738
Prev Vet Med. 2013 Nov 1;112(3-4):230-47
pubmed: 24125696
Curr Top Microbiol Immunol. 2012;359:95-104
pubmed: 22427144
Lancet Infect Dis. 2020 Apr;20(4):445-454
pubmed: 32027842
Vet Clin North Am Equine Pract. 2014 Dec;30(3):579-89
pubmed: 25281398
Emerg Infect Dis. 2015 Feb;21(2):328-31
pubmed: 25626011
PLoS One. 2016 Jun 15;11(6):e0155252
pubmed: 27304985
Emerg Infect Dis. 2022 May;28(5):1043-1047
pubmed: 35447052
Am J Trop Med Hyg. 2011 Nov;85(5):946-51
pubmed: 22049055
Virol J. 2021 Oct 13;18(1):197
pubmed: 34641882
One Health. 2020 Sep 02;10:100162
pubmed: 33117876
Aust Vet J. 2007 Jul;85(7):268-70
pubmed: 17615038
Microbes Infect. 2001 Apr;3(4):307-14
pubmed: 11334748
Emerg Infect Dis. 2022 Mar;28(3):693-704
pubmed: 35202527